Neuralink: UHN selected as Canadian site for CAN-PRIME study
UHN has been selected as the first hospital in Canada to perform a pioneering neurosurgical procedure involving the Neuralink implantable device as part of the CAN-PRIME study, marking a significant milestone in the field of medical innovation. This first-ever procedure in Canada represents an exciting new research direction in neurosurgery and will involve the implantation of a wireless brain-computer interface (BCI) at UHN’s Toronto Western Hospital, the exclusive surgical site in Canada. Neuralink has received Health Canada approval to begin recruiting for this clinical trial in Canada. The goal of the CAN-PRIME Study (short for Canadian Precise Robotically Implanted Brain-Computer Interface), according to the study synopsis, is „to evaluate the safety of our implant (N1) and surgical robot (R1) and assess the initial functionality of our BCI for enabling people with quadriplegia to control external devices with their thoughts.“ Patients…





